What is known on this topic What this paper adds
• Tissue factor (TF) is released from the cell surface in microvesicles (MVs) following the activation of protease activated receptor 2 (PAR2).
• Phosphorylation of TF at Ser253 alone enhanced TF binding to filamin-A, whereas phosphorylation of Ser258 alone reduced binding to filamin-A below that of non-phosphorylated TF.
• Phosphorylation of the cytoplasmic domain of TF at Ser253 promotes the incorporation of TF into MVs in response to PAR2 activation, whereas Ser258 phosphorylation suppresses this process.
• The interaction between TF and filamin-A increased following PAR2 activation and occurred at the same time as TF phosphorylation at Ser253 and TFpositive MV release.
• The cytoskeletal protein filamin-A is also required for the incorporation of TF into MVs. Phosphorylation of both serine residues 253 and 258 within the cytoplasmic domain of TF is known to enhance the interaction between TF and filamin-A.
• Filamin-A does not regulate the transport of TF to the cell surface, but may translocate TF to cholesterol-rich microdomains where TF procoagulant activity is enhanced and where TF is incorporated into and released in MVs. Tissue factor (TF) is a transmembrane protein that is expressed on the cell surface and released from cells in microvesicles (MVs). TF has a small cytoplasmic domain, which has no intrinsic kinase activity, and is not required for the procoagulant activity of TF [1] .
However, serine residues 253 and 258 within the cytoplasmic domain of TF are phosphorylated following the activation of protein kinase C alpha (PKCα) [2] and p38 [3] respectively. The phosphorylation of Ser253 occurs first, which subsequently allows Ser258 to be phosphorylated [2] . TF phosphorylation mediates a number of cellular processes including cell migration [4] , angiogenesis [5] , VEGF production [6] and metastasis [7] . We have previously shown that the incorporation of TF into MVs following protease-activated receptor 2 (PAR2) activation is differentially regulated by the phosphorylation of Ser253 and Ser258, whereby phosphorylation of Ser253 promotes the incorporation of TF into MVs and phosphorylation of Ser258 suppresses this process [8] . We have also demonstrated that the presence of filamin-A is crucial for TF to be incorporated into MVs in response to PAR2 activation [9] .
Filamin-A is a 280 kDa protein composed of an N-terminal actin-binding domain and 24 Iglike repeats [10] . Repeat 24 allows filamin-A molecules to dimerise to form a "leaf spring" structure [10] , while the actin binding domain cross-links actin filaments. Filamin-A also binds to over 90 transmembrane and cytosolic proteins [11] , most of which interact with Ig repeats 16-24 of filamin-A, which regulates the function and cellular localisation of these proteins [11] . TF also binds to this region of filamin-A through a direct interaction between the cytoplasmic domain of TF and the C-terminus repeats 22-24 of filamin-A [12] .
Furthermore, phosphorylation of the cytoplasmic domain of TF enhances the binding to filamin-A compared to non-phosphorylated TF [12] . However, the contribution of the individual phosphorylation at Ser253 and Ser258 to this interaction has not been explored. The aim of this study was to determine whether the individual phosphorylation of TF at Ser253 and Ser258 differentially modulates the binding affinity of TF for filamin-A, in an attempt to further clarify the mechanism by which the sequential phosphorylation of Ser253 and Ser258 may regulate the incorporation of TF into MVs in a filamin-A dependent mechanism.
MATERIALS AND METHODS

Cloning and expression of repeats 22-24 of filamin-A
A synthetic gene encoding repeats 22-24 of filamin-A (amino acids 2329-2647) (GeneArt, Thermo Fisher Scientific, Paisley, UK) was sub-cloned into a bacterial expression vector in tandem with a N-terminal His (×6) tag by the Protein Expression Laboratory (University of Leicester, UK). The insert sequence was confirmed and the plasmid was transformed into E.coli BL21(DE3). Recombinant protein was isolated and purified on a nickel column using an AKTA purifier (GE Healthcare Life Sciences, Bucks, UK). The recombinant filamin-A was dialysed overnight in PBS and then examined by SDS-PAGE and western blot analysis to ensure it had the correct molecular weight (36 kDa) and was recognised by a filamin-A antibody (EP2405Y) (GeneTex Inc., CA, USA) directed against the 24 th C-terminal repeat of filamin-A (Supplemental Figure 1) . and nuclei were labelled with DAPI (2 µg/ml) (Sigma). Images were acquired using an min. Filtered platelet-poor pooled human plasma containing CTI (18.3 µg/ml) (60 µl) was then added to each well and thrombin generation was measured using the CAT assay in the absence of any exogenous reagent. TF-specific thrombin generation was calculated as the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
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Statistical analysis
Data represent the calculated mean values from the number of experiments stated in the figure legends ± the calculated standard error of the mean (SEM). The data were analysed using the statistical package for the social sciences (SPSS). Significance was determined using one-way ANOVA and the Tukey's honestly significance test and values of p<0.05 were considered to be significant. To confirm these data, non-biotinylated phospho-Ser253 and non-biotinylated double phosphorylated TF peptides were used to compete out binding of biotinylated TF peptides in different phosphorylation states. In the presence of the highest concentration of the nonbiotinylated phospho-Ser253 peptide, the binding of the phospho-Ser258 peptide was reduced The release of TF-positive MVs and the phosphorylation of TF at serine residues 253 and 258 in endothelial cells following PAR2 activation has been shown previously [8] .
RESULTS
Phosphorylation
Activation of PAR2 results in increased proximity of TF and filamin-A in MDA-MB-
cells and primary endothelial cells
The proximity of TF and filamin-A was examined by an in situ procedure employing the Duolink proximity ligation assay, which permits the detection of two molecules within close (≤ 40 nm) proximity of each other [13] . Close proximity between TF and the C-terminus of was not possible, and pull-down assays using the TF cytoplasmic domain peptides conjugated to magnetic beads did not pull-down filamin-A from cell lysates. 
Disruption of lipid rafts reduces TF-MV release and suppresses PAR2-mediated increases in cell surface TF activity
A recent study has shown that macrophage-derived TF-positive MVs originate from lipid rafts [14] . Furthermore, TF associated with cholesterol-rich microdomains has been shown to possess increased procoagulant activity [15] . Therefore, since filamin-A knock-down suppressed PAR2-mediated increases in cell surface TF activity ( Figure 4A Figure 5B) . Consequently, the outcome of concurrent filamin-A knock-down and lipid raft disruption on TF activity on the surface of cells was examined. Cell surface TF activity was reduced in the presence of MβCD alone ( Figure 5C ), in agreement with previous reports that lipid rafts support TF procoagulant activity [15, 16] . Both pre-incubation of the cells with MβCD or the suppression of filamin-A expression reduced cell surface TF activity to similar levels following PAR2 activation. In Figure 5C ). To examine whether TF phosphorylation alone is sufficient for TF to be translocated to lipid rafts and therefore increase TF procoagulant activity, MDA-MB-231 cells were incubated with PMA (100 nM)
for 30 min to directly activate PKCα and induce TF phosphorylation [17] . Analysis of PMAtreated and untreated cells showed no differences in levels of cell surface TF activity, which was also unaltered by suppression of filamin-A expression (Supplemental Figure 10 ).
Increased levels of phosphatidylserine (PS) on the outer leaflet of the plasma membrane can also augment TF procoagulant activity [18] . Therefore the effect of the suppression of filamin-A expression on levels of cell surface PS was examined by flow cytometry for annexin V binding, and showed that cells with filamin-A knock-down had marginally higher levels of cell surface PS compared to cells transfected with control siRNA (Figure 6 ).
DISCUSSION
We previously reported that the incorporation of TF into MVs in response to PAR2 activation is promoted by the phosphorylation of TF at Ser253, and subsequently suppressed by phosphorylation of Ser258 [8] . Furthermore, we have shown that filamin-A is essential for the increased incorporation of TF into MVs following PAR2 activation [9] . However, the underlying mechanisms of filamin-A-dependent incorporation of TF into MVs are not known. Since filamin-A binds to the cytoplasmic domain of TF in a phosphorylationdependent manner [12] the main aim of this study was to examine the individual role of Ser253 and Ser258 in the interaction between filamin-A and TF. In vitro binding assays revealed that both the phospho-Ser253 TF peptide and dual phosphorylated TF peptide had the highest binding affinities for the C-terminus repeats 22-24 of filamin-A ( Figure 1A ). In contrast, the phospho-Ser258 TF peptide showed a low binding affinity for repeats 22-24 of Therefore, proximity ligation assays were employed to detect TF: filamin-A interactions in situ. We used MDA-MB-231 cells throughout the study as they release TF in a filamin-A dependent manner in response to PAR2 activation (Figures 2A&B) [9] . Increased proximity between TF and filamin-A following PAR2 activation was shown to be transient in both MDA-MB-231 cells ( Figure 3 ) and endothelial cells (Supplemental Figure 5C ). The direct interaction of the C-terminus of filamin-A with the cytoplasmic domain of TF phosphorylated at both Ser253 and Ser258 has been demonstrated previously [12] . Also, TF has been shown to co-localise with filamin-A at the leading edge of spreading epithelial cells [19] and in migrating smooth muscle cells [20] . However, this is the first study to demonstrate the opposing roles of the individual phosphorylation of TF at Ser253 and Ser258 on its interaction with filamin-A. The dissimilar binding affinities between filamin-A and TF in different phosphorylation states may arise due to structural changes within the cytoplasmic domain of TF which occur following phosphorylation of Ser253 and Ser258 [21] , and/or changes in the structure of filamin-A following cellular activation [22, 23] . Further [24, 25] and regulate receptor internalisation [26, 27] . It is possible that filamin-A links TF to the actin cytoskeleton to translocate TF to sites of MV release. Furthermore, the interaction between filamin-A and TF is unlikely to have a role in the transport of TF from intracellular stores to the cell surface [28] , since suppression of filamin-A expression resulted in increased levels of cell surface TF antigen. This is in agreement with an observation by Rothmeier et al. (2015) that cell surface TF, rather than TF transported from the Golgi, is incorporated into macrophage-derived MVs [14] .
It has been reported that TF-positive MVs are derived from lipid rafts [14, 29, 30, 31] . In agreement with this we found that cholesterol depletion reduced TF-positive MV release (Figures 5A&B) . Furthermore, disruption of lipid rafts using MβCD reduced cell surface TFspecific procoagulant activity ( Figure 5C ). This is in agreement with previous studies that have shown that cholesterol depletion using MβCD reduces TF procoagulant activity by 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w   18 lowering the binding affinity of cell surface TF for FVIIa [15, 16] . Importantly, cell surface PS levels were not reduced by knock-down of filamin-A expression (Figure 6 ), discounting the reduced exposure of PS on the cell surface as the reason for the observed reduction in cell surface TF procoagulant activity on cells with suppression of filamin-A expression.
Furthermore, MβCD did not alter the effect of filamin-A knock-down on TF cell surface activity following PAR2 activation. In fact MβCD had a similar effect as filamin-A knockdown, but there was no additive or co-operative reduction in TF activity ( Figure 5C ). This indicates that both filamin-A knock-down and treatment with MβCD work through a similar mechanism, interfering with the association of TF with cholesterol-rich microdomains necessary for optimal TF activity. Therefore, the interaction with filamin-A is likely to be required for the translocation of cell surface TF following PAR2 activation to cholesterol rich microdomains, that subsequently allows incorporation of active TF into MVs. This is compatible with the concept that transmembrane proteins can translocate to lipid rafts following cellular activation [32, 33] , and filamin-A has been shown to cluster and retain receptors at the cell surface [24, 25, 34] . TF is known to be associated within distinct fractions following membrane fractionation by sucrose density gradient ultracentrifugation [16] . Therefore, in future experiments we aim to examine the lipid raft distribution of cell surface TF following suppression of filamin-A expression.
In conclusion, this study has for the first time demonstrated the opposing roles of Ser253 and Ser258 phosphorylation in the interaction between TF and filamin-A. Furthermore, the data suggest the filamin-A dependent translocation of TF into lipid-rich microdomains as the mechanism by which filamin-A mediates the incorporation and release of TF into MVs following PAR2 activation.
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